Paper39495463
Persistent Ferroptosis Modulates Cardiac Remodeling and M2 Macrophage Polarization, Which Can be Mitigated by Astaxanthin During Myocardial Infarction Recovery.
Shen C and 6 others. Cardiovasc Toxicol, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Persistent Ferroptosis Modulates Cardiac Remodeling and M2 Macrophage Polarization, Which Can be Mitigated by Astaxanthin During Myocardial Infarction Recovery. Papers, record 39495463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39495463
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Persistent Ferroptosis Modulates Cardiac Remodeling and M2 Macrophage Polarization, Which Can be Mitigated by Astaxanthin During Myocardial Infarction Recovery.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferroptosis | Major topic |
| Ventricular Remodeling | Major topic |
| Myocardial Infarction | Major topic |
| Macrophages | Major topic |
| Antioxidants | Major topic |
| Ventricular Function, Left | Major topic |
| Myocardium | Major topic |
| Anti-Inflammatory Agents | Major topic |
| Macrophage Activation | Major topic |
| Animals | |
| Xanthophylls | |
| Male | |
| Disease Models, Animal | |
| Phospholipid Hydroperoxide Glutathione Peroxidase | |
| Lipid Peroxidation | |
| Recovery of Function | |
| Fibrosis | |
| Coenzyme A Ligases | |
| Rats, Sprague-Dawley | |
| Iron | |
| Signal Transduction | |
| Ferroportin | |
| Phenotype | |
| Quinoxalines | |
| Spiro Compounds |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82201549 | National Natural Science Foundation of China | PubMed | ||
| 81772044 | National Natural Science Foundation of China | PubMed |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35511857 | Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. | Eur Heart J | 2022 | https://conductscience.org/library/papers/35511857 | PubMed |
| 2 | 29247693 | Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes. | Matrix Biol | 2019 | https://conductscience.org/library/papers/29247693 | PubMed |
| 3 | 28660552 | Adverse Remodeling and Reverse Remodeling After Myocardial Infarction. | Curr Cardiol Rep | 2017 | https://conductscience.org/library/papers/28660552 | PubMed |
| 4 | 27126533 | Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction. | J Am Coll Cardiol | 2016 | https://conductscience.org/library/papers/27126533 | PubMed |
| 5 | 19047340 | Oxidative stress and left ventricular remodelling after myocardial infarction. | Cardiovasc Res | 2009 | https://conductscience.org/library/papers/19047340 | PubMed |
| 6 | 29868933 | Mapping macrophage polarization over the myocardial infarction time continuum. | Basic Res Cardiol | 2018 | https://conductscience.org/library/papers/29868933 | PubMed |
| 7 | 29106912 | Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. | Transl Res | 2018 | https://conductscience.org/library/papers/29106912 | PubMed |
| 8 | 31841135 | Cardiac monocytes and macrophages after myocardial infarction. | Cardiovasc Res | 2020 | https://conductscience.org/library/papers/31841135 | PubMed |
| 9 | 34312370 | Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. | Cell Death Discov | 2021 | https://conductscience.org/library/papers/34312370 | PubMed |
| 10 | 35685642 | Resveratrol Attenuate Myocardial Injury by Inhibiting Ferroptosis Via Inducing KAT5/GPX4 in Myocardial Infarction. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35685642 | PubMed |
| 11 | 36987924 | Alox15/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis. | Circulation | 2023 | https://conductscience.org/library/papers/36987924 | PubMed |
| 12 | 36061338 | Iron Overload via Heme Degradation in the Endoplasmic Reticulum Triggers Ferroptosis in Myocardial Ischemia-Reperfusion Injury. | JACC Basic Transl Sci | 2022 | https://conductscience.org/library/papers/36061338 | PubMed |
| 13 | 35783244 | Role of Ferroptosis in Fibrotic Diseases. | J Inflamm Res | 2022 | https://conductscience.org/library/papers/35783244 | PubMed |
| 14 | 34331963 | FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis. | Metabolism | 2021 | https://conductscience.org/library/papers/34331963 | PubMed |
| 15 | 36252699 | Astaxanthin attenuates ferroptosis via Keap1-Nrf2/HO-1 signaling pathways in LPS-induced acute lung injury. | Life Sci | 2022 | https://conductscience.org/library/papers/36252699 | PubMed |
| 16 | 27842070 | ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. | Nat Chem Biol | 2017 | https://conductscience.org/library/papers/27842070 | PubMed |
| 17 | 12907459 | Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. | Blood | 2003 | https://conductscience.org/library/papers/12907459 | PubMed |
| 18 | 29348018 | Myocardial Inflammation Predicts Remodeling and Neuroinflammation After Myocardial Infarction. | J Am Coll Cardiol | 2018 | https://conductscience.org/library/papers/29348018 | PubMed |
| 19 | 32311424 | Ferroptosis as an emerging target in inflammatory diseases. | Prog Biophys Mol Biol | 2020 | https://conductscience.org/library/papers/32311424 | PubMed |
| 20 | 32979361 | Tocilizumab mimotope alleviates kidney injury and fibrosis by inhibiting IL-6 signaling and ferroptosis in UUO model. | Life Sci | 2020 | https://conductscience.org/library/papers/32979361 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42967865 | From ER and mitochondria to contact sites: integrated regulation of ferroptosis in cardiovascular diseases. | Redox Rep | 2026 | https://conductscience.org/library/papers/42967865 | PubMed |
| 42948295 | Astaxanthin Inhibits ox-LDL-Induced Early Endothelial Progenitor Cells Oxidative Stress and Apoptosis Through Nrf2 Activation. | Stem Cells Int | 2026 | https://conductscience.org/library/papers/42948295 | PubMed |
| 42415091 | Metabolic regulation of macrophage polarization in myocardial infarction: from mechanisms to targeted therapies. | J Transl Med | 2026 | https://conductscience.org/library/papers/42415091 | PubMed |
| 41507627 | From nutrition to therapeutics: the diverse inflammopharmacological and biomedical roles of astaxanthin. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/41507627 | PubMed |
| 41394800 | Recent advances in the interaction of ferroptosis and immune-mediated inflammation in cardiovascular disease: mechanisms and therapeutic potential. | Front Immunol | 2025 | https://conductscience.org/library/papers/41394800 | PubMed |
| 41126838 | Deciphering macrophage differentiation and cell death dynamics in heart failure: a single-cell sequencing odyssey. | Front Immunol | 2025 | https://conductscience.org/library/papers/41126838 | PubMed |
| 40376919 | Auricular Transcutaneous Vagus Nerve Stimulation Enhances Post-Stroke Neurological and Cognitive Recovery in Mice by Suppressing Ferroptosis Through α7 Nicotinic Acetylcholine Receptor Activation. | CNS Neurosci Ther | 2025 | https://conductscience.org/library/papers/40376919 | PubMed |
| 39906141 | Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and in vivo/vitro experiments. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/39906141 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACSL4 | 2182 | PubTator's text mining | https://conductscience.org/library/genes/2182 | NCBI Gene |
| ACTA1 | 58 | PubTator's text mining | https://conductscience.org/library/genes/58 | NCBI Gene |
| CD68 | 968 | PubTator's text mining | https://conductscience.org/library/genes/968 | NCBI Gene |
| GPX4 | 2879 | PubTator's text mining | https://conductscience.org/library/genes/2879 | NCBI Gene |
| SLC40A1 | 30061 | PubTator's text mining | https://conductscience.org/library/genes/30061 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39495463
GET https://conductscience.org/api/papers/v1/39495463/references?page=2